Abstract

Of several thousand peptides presented by the major histocompatibility molecule HLA-A2.1, at least nine are recognized by melanoma-specific cytotoxic T lymphocytes (CTLs). Tandem mass spectrometry was used to identify and to sequence one of these peptide epitopes. Melanoma-specific CTLs had an exceptionally high affinity for this nine-residue peptide, which reconstituted an epitope for CTL lines from each of five different melanoma patients tested. Recognition by multiple CTL lines suggests that this may be a promising candidate for use in peptide-based melanoma vaccines.

Keywords

CTL*Cytotoxic T cellEpitopePeptideMelanomaMajor histocompatibility complexHuman leukocyte antigenBiologyPeptide sequenceImmunologyCancer researchMolecular biologyChemistryAntigenBiochemistryIn vitroGene

Affiliated Institutions

Related Publications

Publication Info

Year
1994
Type
article
Volume
264
Issue
5159
Pages
716-719
Citations
829
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

829
OpenAlex

Cite This

Andrea L. Cox, Jonathan Skipper, Ye Chen et al. (1994). Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines. Science , 264 (5159) , 716-719. https://doi.org/10.1126/science.7513441

Identifiers

DOI
10.1126/science.7513441